Computational Prediction of Spike Protein Mutations and ACE2 Binding Dynamics in Emerging Coronaviruses

Introduction

The angiotensin-converting enzyme 2 (ACE2) receptor serves as the primary cellular entry portal for multiple coronaviruses across mammalian and avian hosts [1]. The spike glycoprotein, particularly its receptor-binding domain (RBD), undergoes continuous mutational variation that modulates binding affinity and host range [2]. Computational prediction of these mutations and their impact on ACE2 binding dynamics has become central to veterinary virology surveillance and preclinical assessment of cross-species transmission risk [3]. This article reviews the biophysical and algorithmic frameworks for evaluating RBD-ACE2 interactions, including homology modeling, molecular dynamics (MD) simulations, docking algorithms, and machine learning classifiers trained on deep mutational scanning data [4, 5]. Emphasis is placed on host-range parallels between human-adapted and animal-adapted coronaviruses, leveraging the extensive body of structural and evolutionary data now available [6, 7].

Molecular Basis of Spike-ACE2 Interaction

Coronavirus spike proteins are class I fusion glycoproteins that adopt a metastable prefusion conformation [8]. The RBD, located in the S1 subunit, adopts either a "standing-up" or "lying-down" conformation relative to the trimer axis [9]. ACE2 binding requires the RBD to be in the standing-up state, exposing a receptor-binding motif (RBM) that directly contacts the N-terminal helix of ACE2 [10]. Key contact residues in the RBM include a spatially conserved cluster of aromatic and charged side chains that form hydrogen bonds and van der Waals contacts with ACE2 [1, 11]. Mutations at these positions can alter binding free energy by several kcal/mol, shifting the equilibrium toward higher or lower affinity [12, 4].

The binding interface is characterized by a relatively large buried surface area (typically 800-1000 Ų) and a pronounced electrostatic complementarity between the positively charged RBM and the negatively charged ACE2 peptidase domain [9, 8]. These electrostatic features can be quantified through Poisson-Boltzmann continuum solvation models [13]. The desolvation penalty upon complex formation is offset by favorable polar and nonpolar interactions, making the binding energetics highly sensitive to single-point substitutions [14].

Computational Methods for Mutation Effect Prediction

Homology Modeling and Structure Preparation

When high-resolution experimental structures are unavailable, homology modeling using templates from the Protein Data Bank provides reliable starting coordinates for the RBD-ACE2 complex [2]. The accuracy of such models depends on sequence identity between the target and template, typically above 60% for closely related coronaviruses [15]. Loop refinement and side-chain rotamer optimization are essential to capture induced-fit conformational changes at the interface [16]. These modeled structures then serve as inputs for subsequent energetic evaluations [9].

Molecular Dynamics Simulations

MD simulations capture the conformational flexibility of the RBD-ACE2 complex under physiological conditions [17]. All-atom simulations using explicit solvent models (e.g., TIP3P water) and consistent force fields (e.g., CHARMM36 or Amber ff14SB) allow calculation of residue-specific fluctuation profiles and principal components of motion [13, 18]. The binding free energy can be approximated using end-point methods such as molecular mechanics generalized Born surface area (MM/GBSA) and molecular mechanics Poisson-Boltzmann surface area (MM/GBSA) [9, 11]. These approaches decompose the total free energy into electrostatic, van der Waals, and nonpolar solvation contributions, revealing which mutations enhance or disrupt binding [13, 19].

Steered MD or umbrella sampling methods can provide potential of mean force (PMF) profiles along the dissociation pathway, yielding more accurate binding free energies than single-trajectory MM/GBSA [17]. However, these methods are computationally intensive and are generally reserved for validating a small set of prioritized mutations [18].

Protein-Protein Docking

Rigid-body docking algorithms, often combined with soft scoring functions, generate ensembles of possible RBD-ACE2 conformations [14]. These docking poses are ranked by a combination of shape complementarity, electrostatic compatibility, and desolvation penalties. The highest-ranking poses are then refined by local minimization and rescored with more accurate energy functions [10, 14]. Docking is particularly useful for predicting the binding mode of novel RBD variants with limited structural information [15].

Machine Learning and Deep Learning Approaches

Machine learning models, especially those based on gradient boosting, random forests, and neural networks, have been trained on large-scale deep mutational scanning datasets to predict binding affinity changes (ΔΔG) from sequence alone [3, 4, 5]. Features typically include evolutionary conservation scores (e.g., from multiple sequence alignments), residue depth, solvent accessibility, and predicted structural stability [20, 21]. Protein language models, such as those using transformer architectures, embed sequence information into high-dimensional latent spaces that capture distant evolutionary relationships [6, 22, 23]. Contrastive learning frameworks further improve generalization by separating variant representations according to their functional consequences [24, 25].

Transfer learning has been successfully applied to coronavirus spike mutation prediction, where a model pretrained on general protein stability data is fine-tuned on RBD-specific binding measurements [5]. The combination of machine learning and iterative experimental feedback loops enables rapid adaptation to newly emerging variants [3, 26]. Hidden Markov models can capture epistatic interactions between residues, revealing compensatory mutations that maintain binding fitness [21].

Mutation Prediction and Binding Affinity Dynamics

Large-scale mutagenesis studies have systematically characterized the effects of every possible single amino acid substitution in the RBM on ACE2 affinity [4]. These data reveal a rugged fitness landscape where only a subset of mutations, primarily those at positions 484, 501, and 505, consistently enhance binding [1, 2]. Structural constraints limit the number of viable mutations that preserve RBD folding and expression [2, 15]. For example, mutations at the RBD core often destabilize the domain and reduce ACE2 binding, while surface-exposed RBM residues are more tolerant of substitution but risk immune recognition [9, 27].

Computational scanning of combinatorial mutations using genetic algorithm-driven structural modeling can identify high-order cooperative effects that single-mutation analysis misses [15, 17]. These scans have uncovered allosteric networks linking distant residues to the binding interface, where mutations outside the RBM propagate to shift the conformational ensemble toward a more ACE2-compatible state [16, 19]. Binding free energy computations on these ensembles demonstrate that some variants achieve high affinity through enhanced RBM-ACE2 hydrogen bonding networks, while others rely on reduced off-rates due to increased hydrophobic burial [11, 28].

Immune escape mutations, which reduce antibody binding, can simultaneously alter ACE2 affinity [9, 27]. The trade-off between immune evasion and receptor engagement defines the evolutionary trajectory of the spike protein [29, 30]. Multiscale modeling that couples RBD-ACE2 binding with antibody epitope mapping reveals that certain mutations predominantly affect one function without significantly compromising the other [13, 18, 31]. These "dual-function" hotspots are of particular concern for vaccine and therapeutic design [32, 33].

Phylogenetic Surveillance and High-Risk Variant Identification

Phylogenetic surveillance of coronavirus spike sequences from both human and animal samples enables real-time tracking of mutational patterns [6, 7]. Anomaly detection using deep autoencoders can flag sequences whose feature representation diverges from established clusters, indicating potential functional novelty [25]. Protein language models that encode evolutionary trajectories can extrapolate future mutation pathways likely to arise under selective pressure [6, 22].

Integrating phylogenetic data with structural predictions allows prioritization of variants for experimental characterization. A typical workflow involves (1) collection of spike sequences from public databases, (2) alignment and phylogenetic tree construction, (3) identification of residues under positive selection (e.g., dN/dS ratios), (4) structural mapping of selected positions onto the RBD-ACE2 complex, (5) computational binding affinity prediction using either physics-based or machine learning methods, and (6) experimental validation using surface plasmon resonance or biolayer interferometry [3, 20]. This pipeline has been applied to identify bat coronavirus strains with high zoonotic potential by predicting their affinity for various mammalian ACE2 orthologs [1, 10].

Integration with Experimental Data

Computational predictions require rigorous experimental benchmarking. Deep mutational scanning data provide quantitative binding scores for thousands of variants, enabling direct comparison with in silico predictions [4]. Assays measuring spike-ACE2 binding, such as ELISA-based competition or pseudovirus neutralization, offer functional validation for computational models [10, 17]. The iterative cycle of prediction and experiment accelerates the characterization of emerging variants, as demonstrated by the rapid assessment of Omicron lineage subvariants [3, 26].

Workflow for Computational Prediction of Spike Mutation Effects

flowchart TD
    A[Sequence / Structure Data], > B{Homology Modeling or Crystal Structure?}
    B, >|Experimental| C[Template-based Model Building]
    B, >|Predicted| D[AlphaFold / RoseTTAFold Structure]
    C, > E[Molecular Dynamics Simulation]
    D, > E
    E, > F[Binding Free Energy Calculation MM/GBSA, PMF]
    F, > G[Residue-wise Decomposition]
    G, > H[Mutation Scanning in Silico]
    H, > I[Machine Learning Prediction ΔΔG]
    I, > J[Prioritize High-Risk Variants]
    J, > K[Experimental Validation Binding Assays]
    K, > L[Update Phylogenetic Database]
    L, > A

The diagram illustrates the cyclical nature of computational and experimental workflows, where each validated variant feeds back into model retraining and sequence surveillance [3, 6, 4].

Conclusion

Computational prediction of spike protein mutations and ACE2 binding dynamics has matured into a robust discipline that integrates structural biology, statistical physics, and machine learning. The methods reviewed here, homology modeling, molecular dynamics, docking, and deep learning, are essential for anticipating host-range shifts and immune escape in coronaviruses of veterinary importance. Continued development of transfer learning approaches and protein language models will further improve predictive accuracy [6, 5]. Linking these computational tools with global phylogenetic databases such as GISAID enables proactive risk assessment and informs vaccine and diagnostic strategies for both animal and human populations [7, 25].

References

[1] Usama M, Azeem M, Mustafa G. Computational prediction of binding affinity and structural impact of three Pakistani SARS-CoV-2 spike RBD variants on human ACE2 interaction. PLoS One. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41920812/

[2] Herzig JC, Magwira ML, Lovell SC. Structural Constraints Acting on the SARS-CoV-2 Spike Protein Reveal Limited Space for Viral Adaptation. Genome Biol Evol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41876430/

[3] Sheffield T, Bruneau RC, Won S et al. Combining machine learning and iterative experiments to keep pace with emerging viral variants of concern. PLoS Comput Biol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42308256/

[4] Xia H, Wei D, Guo Z et al. Machine Learning on the Impacts of Mutations in the SARS-CoV-2 Spike RBD on Binding Affinity to Human ACE2 Based on Deep Mutational Scanning Data. Biochemistry. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40811092/

[5] Govender S, Morgan E, Ramahala R et al. Transfer learning towards predicting viral missense mutations: A case study on SARS-CoV-2. Comput Struct Biotechnol J. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40352476/

[6] Lamb KD, Hughes J, Lytras S et al. From single-sequences to evolutionary trajectories: protein language models capture the evolutionary potential of SARS-CoV-2. Nat Commun. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41714330/

[7] Raharinirina NA, Gubela N, Börnigen D et al. SARS-CoV-2 evolution on a dynamic immune landscape. Nature. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/39880955/

[8] Neander L, Hannemann C, Netz RR et al. Quantitative Prediction of Protein-Polyelectrolyte Binding Thermodynamics: Adsorption of Heparin-Analog Polysulfates to the SARS-CoV-2 Spike Protein RBD. JACS Au. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/39886596/

[9] Alshahrani M, Parikh V, Foley B et al. Dissecting binding and immune evasion mechanisms for ultrapotent Class I and Class 4/1 neutralizing antibodies of SARS-CoV-2 spike protein using a multi-pronged computational approach: neutral frustration architecture of binding interfaces and immune escape hotspots drives adaptive evolution. Phys Chem Chem Phys. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41623222/

[10] Yao Q, Mahase V, Hou W et al. Computational and experimental identification of potential neutralizing peptides derived from human ACE2 against SARS-CoV-2 infection. J Virol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41615206/

[11] Alshahrani M, Parikh V, Foley B et al. Mutational Scanning and Binding Free Energy Computations of the SARS-CoV-2 Spike Complexes with Distinct Groups of Neutralizing Antibodies: Energetic Drivers of Convergent Evolution of Binding Affinity and Immune Escape Hotspots. Int J Mol Sci. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40003970/

[12] van den Boom M, Schultes E, Hankemeier T. Structure-based prediction of SARS-CoV-2 variant properties using machine learning on mutational neighborhoods. Front Bioinform. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40989750/

[13] Alshahrani M, Parikh V, Foley B et al. Multiscale Modeling and Dynamic Mutational Profiling of Binding Energetics and Immune Escape for Class I Antibodies with SARS-CoV-2 Spike Protein: Dissecting Mechanisms of High Resistance to Viral Escape Against Emerging Variants. Viruses. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40872744/

[14] Yu G, Bi X, Ma T et al. CATH-ddG: towards robust mutation effect prediction on protein-protein interactions out of CATH homologous superfamily. Bioinformatics. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40662779/

[15] Di Salvatore V, Maleki A, Mohajer B et al. Exploring SARS-CoV-2 spike protein mutations through genetic algorithm-driven structural modeling. Bioinform Adv. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41268478/

[16] Alshahrani M, Parikh V, Foley B et al. Dynamic mutational profiling of binding interactions and allosteric networks in conformational ensembles of the SARS-CoV-2 spike protein complexes with classes of antibodies targeting cryptic binding sites: confluence of binding and allostery determines molecular mechanisms and hotspots of immune escape. Phys Chem Chem Phys. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40842437/

[17] Sharma A, Maurya S, Kumar S et al. An integrated multiscale computational framework deciphers SARS-CoV-2 resistance to sotrovimab. Biophys J. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/40394898/

[18] Alshahrani M, Parikh V, Foley B et al. Exploring Dynamic Modulation of Binding, Allostery and Immune Resistance in the SARS-CoV-2 Spike Complexes with Classes of Antibodies Targeting Cryptic Binding Sites: Antibody-Specific Augmentations of Conserved Allosteric Architecture Can Influence Evolution of Viral Escape. bioRxiv. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40631092/

[19] Alshahrani M, Parikh V, Foley B et al. Conformational Landscaping and Dynamic Mutational Profiling of Binding Interactions and Immune Escape for Broadly Neutralizing Class I Antibodies with SARS-CoV-2 Spike Protein: Distributed Binding Hotspot Networks Underlie Mechanism of Viral Resistance Against Existing Variants. bioRxiv. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40510568/

[20] Bist PS, Chong KT, Tayara H. Unveiling Viral Escape Mechanisms With Machine Learning: A Transformative Approach to Mutation Analysis for SARS-CoV-2 and Beyond. IEEE Trans Comput Biol Bioinform. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42160252/

[21] Adeniyi AE, Juyal A, Skums P et al. Uncovering Epistatic Interactions in SARS-CoV-2 Evolution Through Hidden Markov Models. J Comput Biol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41719088/

[22] Rancati S, Nicora G, Bergomi L et al. SARITA: a large language model for generating the S1 subunit of the SARS-CoV-2 spike protein. Brief Bioinform. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40755284/

[23] Elkin ME, Zhu X. Paying attention to the SARS-CoV-2 dialect : a deep neural network approach to predicting novel protein mutations. Commun Biol. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/39838059/

[24] Tenekeci S, Sezgin E, Tekir S. A Contrastive Learning Framework for Efficient Viral Escape Prediction. IEEE Trans Comput Biol Bioinform. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41843532/

[25] Rancati S, Nicora G, Prosperi M et al. Forecasting dominance of SARS-CoV-2 lineages by anomaly detection using deep AutoEncoders. Brief Bioinform. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39446192/ *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[26] Suárez-Martín I, Risso VA, Romero-Zaliz R et al. Efficient Searches in Protein Sequence Space Through AI-Driven Iterative Learning. Int J Mol Sci. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40429882/

[27] Nguyen DN, Nguyen QT, Dang TM et al. Antibody escape of SARS-CoV-2 variants of concern on receptor-binding domain: A computational approach. J Theor Biol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41360318/

[28] Alshahrani M, Parikh V, Foley B et al. Quantitative Characterization and Prediction of the Binding Determinants and Immune Escape Hotspots for Groups of Broadly Neutralizing Antibodies Against Omicron Variants: Atomistic Modeling of the SARS-CoV-2 Spike Complexes with Antibodies. Biomolecules. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40001552/

[29] Alshahrani M, Parikh V, Foley B et al. Integrative Computational Modeling of Distinct Binding Mechanisms for Broadly Neutralizing Antibodies Targeting SARS-CoV-2 Spike Omicron Variants: Balance of Evolutionary and Dynamic Adaptability in Shaping Molecular Determinants of Immune Escape. Viruses. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40573332/

[30] Tandel K, Niveditha D, Singh SP et al. Decoding omicron: Genetic insight into its transmission dynamics, severity spectrum and ever-evolving strategies of immune escape in comparison with other SARS-CoV-2 variants. Diagn Microbiol Infect Dis. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/39889436/

[31] Alshahrani M, Parikh V, Foley B et al. Exploring Diverse Binding Mechanisms of Broadly Neutralizing Antibodies S309, S304, CYFN-1006 and VIR-7229 Targeting SARS-CoV-2 Spike Omicron Variants: Integrative Computational Modeling Reveals Balance of Evolutionary and Dynamic Adaptability in Shaping Molecular Determinants of Immune Escape. bioRxiv. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40376091/

[32] Rahimnahal S, Yousefizadeh S, Mohammadi Y. Designing a novel vaccine against COVID-19 based on spike SARS-Cov-2 notable mutations using immunoinformatics approaches. PLoS One. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41746934/

[33] Sussman F, Villaverde DS. On the Nature of the Interactions That Govern COV-2 Mutants Escape from Neutralizing Antibodies. Molecules. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39519847/

[34] da Silva GCS, Paraná VC, de Almeida Rego FF et al. Impact of mutations in immunodominant regions of SARS-CoV-2 variants on recognition by CD8+ T cell: An in silico analysis. J Infect Public Health. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/40359819/

[35] Liu Z, Shen Y, Jiang Y et al. Variation and evolution analysis of SARS-CoV-2 using self-game sequence optimization. Front Microbiol. 2024. URL: https://pubmed.ncbi.nlm.nih.gov/39588108/